EPIM
IDXX icon

Evelyn Partners Investment Management’s Idexx Laboratories IDXX Stock Holding History

Evelyn Partners Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.74K Hold
12
– – ﹤0.01% 366
2025
Q4 		$8.12K Hold
12
– – ﹤0.01% 368
2025
Q3 		$7.67K Hold
12
– – ﹤0.01% 363
2025
Q2 		$6.44K Hold
12
– – ﹤0.01% 369
2025
Q1 		$5.04K Sell
12
-17
-59% -$7.38K ﹤0.01% 375
2024
Q4 		$12K Buy
+29
New +$12.7K ﹤0.01% 348

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Evelyn Partners Investment Management's IDXX Position: Q1 2026 in Review

Evelyn Partners Investment Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 12 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Evelyn Partners Investment Management first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $12K in Q4 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Evelyn Partners Investment Management held 12 shares of Idexx Laboratories worth $6.74K as of Q1 2026.
  • Evelyn Partners Investment Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #366 holding.
  • Evelyn Partners Investment Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Idexx Laboratories position peaked at $12K in Q4 2024.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.